LCS
AUXL

Levin Capital Strategies’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Levin Capital Strategies’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-115,038
Closed -$3.43M – 443
2014
Q3 		$3.43M Sell
115,038
-79,646
-41% -$1.69M 0.05% 143
2014
Q2 		$3.9M Buy
194,684
+111,346
+134% +$2.55M 0.06% 150
2014
Q1 		$2.27M Buy
83,338
+6,120
+8% +$162K 0.04% 164
2013
Q4 		$1.6M Buy
+77,218
New +$1.46M 0.03% 194

Other funds holding AUXL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Levin Capital Strategies's AUXL Position: Q4 2014 in Review

Levin Capital Strategies sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 115,038 shares — an estimated $3.43M sold.

Levin Capital Strategies first reported a position in AUXL in Q4 2013 and held it in 4 quarters. The position peaked at $3.9M in Q2 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • Levin Capital Strategies reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Levin Capital Strategies sold 115,038 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $3.43M.
  • Levin Capital Strategies first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q4 2013 and held it in 4 quarters.
  • Levin Capital Strategies's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.9M in Q2 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on Levin Capital Strategies's 13F filing for Q4 2014, filed 12 Feb 2015.